Michael Porter is considered the world’s greatest authority on competitive strategy and international competitiveness. A Harvard Business School Professor and advisor to governments and businesses alike.
Michael E. Porter is a leading authority on competitive strategy, the competitiveness and economic development of nations, states, and regions and the application of competitive principles to social problems such as health care, the environment and corporate responsibility.
He is the Bishop William Lawrence University Professor at Harvard Business School and is a leading expert on competitiveness strategy, having authored 18 books (including Competitive Strategy, Competitive Advantage, and Redefining Health Care) and more than 125 articles. In 2001, Harvard Business School and Harvard University jointly created the Institute for Strategy and Competitiveness, dedicated to furthering his work. His work has been translated into 17 languages, and his current course, Microeconomics of Competitiveness, is taught in partnership with more than 40 universities worldwide.
He received a B.S.E. with high honors in aerospace and mechanical engineering from Princeton University in 1969, where he was elected to Phi Beta Kappa and Tau Beta Pi. He received an M.B.A. with high distinction in 1971 from the Harvard Business School, where he was a George F. Baker Scholar, and a Ph.D. in Business Economics from Harvard University in 1973.
Professor Porter has served as a strategy advisor to top management in numerous leading U.S. and international companies, among them Caterpillar, DuPont, Procter & Gamble, Royal Dutch Shell, Scotts Miracle-Gro, SYSCO, and Taiwan Semiconductor Manufacturing Company. Professor Porter currently serves on the board of directors of two public companies, Thermo Fisher Scientific Corporation and Parametric Technology Corporation. He also serves as senior strategy advisor to the Boston Red Sox, a major league baseball team. He has advised numerous educational and community organizations on strategy.
Professor Porter is actively involved in assisting governments in the United States and abroad. He plays an active role in U.S. economic policy with the Executive Branch, Congress, and international organizations. He is a founding member of the Executive Committee of the Council on Competitiveness, America’s leading private-sector competitiveness organization made up of chief executive officers of major corporations, unions, and universities. He also chairs the selection committee for the annual Corporate Stewardship Award of the U.S. Secretary of Commerce.
He advises national leaders in numerous countries on competitiveness including Armenia, Colombia, Ireland, Nicaragua, Russia, Rwanda, Saudi Arabia, Singapore, Taiwan, and the United Kingdom. He has personally led major studies of economic strategy for the governments of such countries as Canada, India, Kazakhstan, Libya, New Zealand, Portugal, and Thailand.
He has been honored by governments for his work in Basque Country, Catalonia, Connecticut, and South Carolina. He chaired the Governor’s Council on Economic Growth and Technology in Massachusetts during the period when Massachusetts made dramatic improvements in competitiveness.
Professor Porter’s thinking about economic development for groups of neighboring countries has resulted in a long-term initiative within Central America, including the formation of the Latin American Center for Competitiveness and Sustainable Development (CLACDS), a permanent institution based in Costa Rica.
Professor Porter has been widely recognized for his work. He maintains a long-time interest in the esthetics and business of music and art, having worked on the problems of strategy with arts organizations and aspiring musicians. Professor Porter’s core field is strategy, and this remains a primary focus of his research
- Harnessing competition on value: Health outcomes achieved per dollar spent
- Why care delivery should be organized around the medical condition over the full cycle of care
- Why volume and experience matter in care delivery
- The importance of multi-dimensional outcomes measures: When innovation meets performance
- Rethinking value for the patient: The need for new reimbursement models
- Putting health information technology to work